Benzinga | Nov 9, 2021 11:35AM EST

Fusion Pharmaceuticals Q3 EPS $(0.45) Down From $(0.24) YoY

Fusion Pharmaceuticals (NASDAQ:FUSN) reported quarterly losses of $(0.45) per share. This is a 87.5 percent decrease over losses of $(0.24) per share from the same period last year.